16-fluoro-5-androsten-17-one has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haines, DC; Hursting, SD; James, SJ; Miller, BJ; Perkins, SN; Phang, JM | 1 |
| Hursting, SD; Mei, JJ; Perkins, SN; Phang, JM | 1 |
| Lewbart, ML; Pashko, LL; Schwartz, AG | 1 |
3 other study(ies) available for 16-fluoro-5-androsten-17-one and Body Weight
| Article | Year |
|---|---|
Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one.
Topics: Androstenes; Animals; Antineoplastic Agents; Body Weight; Dehydroepiandrosterone; Genes, p53; Liver; Longevity; Male; Mice; Mice, Knockout; Nucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis | 1997 |
p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages.
Topics: Androstenes; Animals; Blotting, Western; Body Weight; Cells, Cultured; Dehydroepiandrosterone; Down-Regulation; Energy Intake; Genes, p53; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II | 1998 |
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides.
Topics: Androstenes; Animals; Body Weight; Deoxyribonucleosides; Drug Interactions; Female; Mice; Mice, Inbred Strains; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1991 |